B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression

Human Immunology

Volumn 63, Issue 3, 2002, Pages 211-220

  Schuster, Michael ^a   Kocher, Alfred ^a   John, Ranjit ^a   Hoffman, Marion ^a   Ankersmit, Jan ^a   Lietz, Katherine ^a   Edwards, Niloo ^a   Oz, Mehmet ^a   Itescu, Silviu ^a  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

Allosensitization; CD40L; LVAD

Indexed keywords

ALLOANTIBODY; CALCINEURIN; CD40 LIGAND; INTERLEUKIN 2 RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ASSISTED CIRCULATION; B LYMPHOCYTE ACTIVATION; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HEART FAILURE; HUMAN; HUMAN CELL; IMPLANTATION; MONONUCLEAR CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION;

EID: 0036129765     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00380-9     Document Type: Article

References (47)

1. Prevalence and mortality rate of congestive heart failure in the United States
2. Molecular approaches to the characterization of cell and blood/biomaterial interactions
3. Clinical experience with textured blood contacting surfaces in ventricular assist devices
4. Artificial circulatory support with textured interior surfaces: A counterintuitive approach to minimizing thromboembolism
5. Quantitative changes in T-cell populations after left ventricular assist device implantation: Relationship to T-cell apoptosisand soluble CD95
6. Activation-induced T-cell death and immune dysfunction after implantation of left ventricular assist device
7. Factors influencing HLA sensitization in implantable LVAD recipients
8. Preformed IgG antibodies against major histocompatibility class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation
9. Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization
10. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support
11. Decreased production of and response to IL-2 by cultured lymphocytes from patients with systemic lupus erythematosus
12. The interleukin 2 secretion defect in vitro in patients with systemic lupus erythematosus is reversible in rested cultured T cells
13. Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with SLE
14. Determination of anticardiolipin and other antibodies in HIV-1 infected patients
15. Induction of autoantibodies by HIV infection and their significance
16. Selective cleavage of nuclear autoantigens during CD95 (Fa/APO1)-mediated T cell apoptosis
17. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
18. Immunology: New clues to systemic lupus
19. Cell dysfunction depletion in AIDS: The programmed cell death hypothesis
20. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus infected asymptomatic individuals
21. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus
22. Decreased production of interleukin 12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus
23. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo
24. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40
25. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription
26. Autoimmune lpr/lpr mice deficient in CD40 ligand: Spontaneous Ig class switching with dichotomy of autoantibody responses
27. Production of pathogenic antibodies: Cognate interactions between autoimmune T and B cells
28. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera
29. The soluble CD40 ligand sCD154 in systemic lupus erythematosus
30. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells
31. Blys binds to B cells with high affinity and induces activation of the transcription factors NF-kappaB and elf-1
32. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis
33. Platelet-polymer interactions: Morphologic and intracellular free calcium studies of individual human platelets
34. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: Requirement for CD28up-regulation of RE/AP
35. Platelet-polymer interactions: Morphologic and intracellular free calcium studies of individual human platelets
36. Surface coating of hydrophilic-hydrophobic block co-polymers on a poly(acrylonitrile) haemodialyser reduces platelet adhesion and its transmembrane stimulation
37. Inhibition of death receptor signals by cellular FLIP
38. Biochemical mechanisms of IL-2 regulated Fas-mediated T cell apoptosis
39. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation
40. Fungal infections in left ventricular assist device recipients - Incidence, prophylaxis, and treatment
41. Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)
42. Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus
43. Systemic exposure to irradiated apoptotic cells induces autoantibody production
44. Improved outcome in highly sensitized cardiac transplant recipients using intravenous cyclophosphamide